+91 6355337906
sales@ceratapharma.com

Corporate Profile

Home Corporate Profile
Cerata Pharmaceuticals is the leading manufacturer of APIs(Active pharmaceutical ingredients) and Intermediates offering high-quality products with the highest levels of compliance and our API products are trusted by pharmaceutical companies in over 90 countries, reflecting our global footprint and reputation.
Cerata Pharmaceuticals LLP is a fully integrated company involved in the complete lifecycle of Active Pharmaceutical Ingredients (API) including the development, production, and sales of Active Pharmaceutical Ingredients (API), High Potency API and API intermediates.
Cerata Pharmaceuticals has become the go-to choice for pharmaceutical companies looking for high-quality APIs for their formulations. We've achieved this reputation by maintaining cutting-edge facilities and holding ourselves to strict international quality standards. Our commitment is a testament to Cerata's importance in India's pharmaceutical landscape, contributing to the industry's growth and development.
Cerata Pharmaceuticals LLP has been serving the pharmaceutical industry, operating multiple state-of-the-art manufacturing plants spread across India dedicated to the production of APIs. Our APIs have gained a well-deserved reputation for their exceptional quality and cost-effectiveness. This distinction makes them the preferred choice for pharmaceutical companies seeking to manufacture quality products while maintaining cost efficiency and competitiveness.
High quality APIs manufacturing

High Quality

API Manufacturing

At Cerata Pharmaceuticals LLP, we prioritize the quality control of our Active Pharmaceutical Ingredients (APIs) because we recognize their pivotal role as essential raw materials in the production of finished pharmaceutical goods. Our steadfast commitment to excellence and unwavering dedication to delivering the utmost quality products to our valued customers have established Cerata Pharma as a name synonymous with trust within the pharmaceutical industry. We stand as a reliable partner of APIs for pharmaceutical companies seeking to manufacture top-tier, standard and quality-driven products.
We are offering customised solutions to our customers for their requirement of APIs, Drug Intermediates and Formulations and to achieve this result our company Cerata Pharmaceuticals LLP engages in the development of Active Pharmaceutical Ingredients (API) and API intermediates for use in commercial production. In addition to process R&D, we provide stability studies, scale-up and process optimisation, process validations, and commercial manufacturing.
The world-class API manufacturing facilities of Cerata Pharma are spread across 3 locations in India, One unit in Gujarat and two in Himachal Pradesh. Our facilities are aligned with global benchmarks and international standards and are designed to meet the stringent quality standards set by internationally recognized organizations such as WHO and FDA. This commitment to quality is vital in achieving our global growth goals.
Our API Manufacturing facilities also follow the standards of other pharma regulations of the world like KFDA, ANVISA-CADIFA(Brazil), USFDA, MHRA(UK), TGA(Australia), MCC(South Africa), MoH(Sri Lanka), MHLW(Japan), NAFDAC(Nigeria), MEDSAFE(New Zealand), MCAZ(Zimbabwe) and EMEA(Europe). This enables Cerata to deliver our entire range of services to our international clientele for their needs in API and drug substance manufacturing in India.
Our manufacturing capacity for various categories ranges from 100MT/year to 300MT/Year. Cerata Pharma is a well-recognized API manufacturer in India, making a substantial impact in the pharmaceutical sector. Our dedication to quality and innovation shines through in the wide range of Active Pharmaceutical Ingredients (APIs) we manufacture. These APIs serve as the foundation for many essential medications.

Competitive Advantages

Chemical Row Material

Our Key Priorities

We are an Indian pharmaceutical company which believes that everyone has a right to affordable quality medicines.
We have a clear goal of giving patients access to quality and affordable products. For this we are aiming to alter the healthcare paradigm. We are now at strong position to research and develop quality API by optimising cost-effective paths of pharmaceutical chemistry – which is our first step to achieve our goals of patient centricity through optimised chemistry.
Cerata Pharmaceuticals is a well-established manufacturer and supplier of active pharmaceutical ingredients (Pharma API), which serve as crucial components in the production of a wide range of pharmaceutical products. Because of this, our reach for APIs extends to the South East Asia, the Middle East, the Pacific region, and various other parts of the globe. This widespread presence has firmly positioned Cerata Pharma as a prominent and leading player in the pharmaceutical API manufacturing industry of the world.
The company’s product portfolio includes a wide range of APIs like Tacrolimus, Mupirocin, Benzocaine, Procaine, Ropivacaine, Rosuvastatin, Ambroxol, Lumefantrine, Pregabalin and many more.
Over time, powered by our advanced research and development as well as manufacturing capabilities, Cerata has transformed into a trusted partner of preference for pharmaceutical companies worldwide. Our specialization lies in the production of generic Active Pharmaceutical Ingredients (APIs), generic intermediates, and Finished Dosage Forms, solidifying our position as a go-to choice in the pharmaceutical industry.
Cerata Pharma has strategically diversified its business across different geographical regions and therapeutic domains within the pharmaceutical industry. APIs, speciality chemicals and intermediates produced by Cerata find extensive applications in the pharmaceutical sector. The company has not only established a strong presence in the Indian market but also expanded its footprint on the global stage.
In addition to its core operations, Cerata Pharma engages in contract manufacturing and outsourcing, providing generic pharmaceutical formulations and medicines to healthcare companies, governments, NGOs, and hospitals. Cerata Pharmaceuticals LLP has a strong presence in the pharmaceutical market and is recognized as a trustworthy and reliable manufacturer and supplier of APIs and high-quality medicines.
with its commitment to quality, innovation, and customer satisfaction Cerata Pharmaceuticals became a leading manufacturer and supplier of Active pharmaceutical ingredients (Pharma API) and medicines in India and around the world and the company is poised to continue its growth and success in the coming years.
We have introduced an extensive range of pharmaceutical formulations, building a strong reputation for delivering high-quality products and earning the trust of loyal clients. Additionally, our company specializes in providing generic pharmaceutical formulations on a "Make-to-order" basis, facilitating bulk supply to hospitals, corporate health centres, municipalities, and international export markets.
Our operations span both domestic and international markets. Currently, we are supplying a range of products including Active Pharmaceutical Ingredients (APIs), Intermediates, Finished Dosage Formulations (FDFs), and Specialty Chemicals (SCs) within the domestic market and products have also reached international markets like the South Asia region, Africa and Middle East (Gulf Countries) region and Latin America region. This global presence underscores the company's commitment to serving a wide range of customers and meeting diverse pharmaceutical needs worldwide.
We have also successfully exported our products to countries such as Indonesia, Sri Lanka, Japan, Ireland, England, Thailand, Vietnam, Singapore, Brazil, Chile and other countries of Europe and also the countries of South East Asia, the Middle East, and North Africa (MENA Region). This expansion highlights our commitment to serving a broader global clientele.
We are in the process of applying for 25 formulation registrations in countries like Ghana, Georgia, Cambodia, Myanmar, Nigeria and Kenya. These product registrations represent a significant step towards boosting our exports and enhancing our pharmaceutical business operations. Under the visionary guidance of our management, Cerata is actively engaged in participating in trade fairs and exhibitions, both in India and worldwide. This strategic approach allows us to establish a strong presence in international markets, with a focus on Europe, Gulf countries and Latin American countries. These efforts are aimed at expanding its presence and making a lasting impact in international markets.
Our company, along with its skilled executives, has cultivated strong expertise in innovation across various domains, including bulk drugs, APIs, speciality chemicals and pharmaceutical formulations. This expertise allows us to develop products with wide-ranging applications within the pharmaceutical industry. Our success is driven by a team of highly skilled professionals who are deeply dedicated to safeguarding the safety, efficacy, and quality of our products. Their expertise ensures that we consistently deliver pharmaceutical solutions of the highest calibre to meet the needs of our customers and uphold our unwavering commitment to quality and integrity.
Cerata Pharmaceuticals LLP holds a prominent position within the pharmaceutical sector, widely recognized for its unwavering commitment to delivering standard products and services. Our core expertise lies in the production and distribution of Active Pharmaceutical Ingredients (APIs) and pharmaceutical medicines, and we actively engage in the marketing of pharmaceuticals within the domestic market. This dedication underscores our mission to provide quality healthcare solutions to our valued customers.